CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Rifapentine Tablet, Film Coated
FDA source answer
FDA source rows are resolved or no longer current.
FDA source statuses: Resolved. First FDA posting: 2020-03-25. Latest FDA row update: 2026-08-06.
FDA lists 1 package records, with companies: Sanofi-Aventis U.S. LLC, sanofi-aventis U.S. LLC. Package NDCs: 0088-2102-24.
FDA shortage reason: Not stated in the grouped FDA source rows.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Sanofi-Aventis U.S. LLC | 0088-2102-24 | Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24) | Not stated | 2026-08-06 |
Source facts
Grouped generic ingredient: Rifapentine Tablet, Film Coated · 1 package records
Therapeutic categories: Anti-Infective
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.